These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8975729)

  • 41. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic stratification of Wilms tumor: is WT1 gene analysis ready for prime time?
    Geller JI
    Cancer; 2008 Sep; 113(5):893-6. PubMed ID: 18618514
    [No Abstract]   [Full Text] [Related]  

  • 43. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
    McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
    Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiologic features of Wilms tumor.
    Birch JM; Breslow N
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1157-78. PubMed ID: 8591959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
    Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
    Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
    [No Abstract]   [Full Text] [Related]  

  • 47. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial Wilms tumor.
    Ruteshouser EC; Huff V
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study.
    Breslow NE; Beckwith JB
    J Natl Cancer Inst; 1982 Mar; 68(3):429-36. PubMed ID: 6278194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Principles of Wilms' tumor biology.
    Coppes MJ; Pritchard-Jones K
    Urol Clin North Am; 2000 Aug; 27(3):423-33, viii. PubMed ID: 10985142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical overview of WT1 gene mutations.
    Little M; Wells C
    Hum Mutat; 1997; 9(3):209-25. PubMed ID: 9090524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
    Reid S; Renwick A; Seal S; Baskcomb L; Barfoot R; Jayatilake H; Pritchard-Jones K; Stratton MR; Ridolfi-Lüthy A; Rahman N; ;
    J Med Genet; 2005 Feb; 42(2):147-51. PubMed ID: 15689453
    [No Abstract]   [Full Text] [Related]  

  • 58. [WT1 (Wilms Tumor 1). Tumor suppressor gene].
    Bull Cancer; 1998 Dec; 85(12):983-4. PubMed ID: 9988551
    [No Abstract]   [Full Text] [Related]  

  • 59. Familial primary hyperparathyroidism complicated with Wilms' tumor.
    Kakinuma A; Morimoto I; Nakano Y; Fujimoto R; Ishida O; Okada Y; Inokuchi N; Fujihira T; Eto S
    Intern Med; 1994 Feb; 33(2):123-6. PubMed ID: 7912571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Genetic events and molecular biology of Wilms' tumor].
    Navajas Gutiérrez A; Pérez-Saracho Taramona M
    An Esp Pediatr; 1997 Feb; 46(2):105-8. PubMed ID: 9157794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.